Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...
The comments come as Sanofi reported Thursday that its total vaccine sales fell 2.5% in the fourth quarter and 1.2% for the ...
Recently, The Phia Group ("Phia") determined that some personal information may have been involved in a data security incident that occurred between July 8 and July 9, 2024. The incident began on July ...
The amazing advances made in cutaneous immunology in recent years have led to the development of new therapies in epidermal ...
News-Medical.Net on MSN
Research uncovers alternative inflammatory pathway in rheumatoid arthritis treatment
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...
News Medical on MSN
Gut microbiome may be a central player in the body's response to cancer
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed ...
While not keeping up with pugs or bloodhounds in the nose department, German Shepherds also have a keen sense of smell, ...
Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research ...
A team of scientists has replicated one of Thomas Edison's early experiments from his quest to make the lightbulb, but with ...
An international study led by the University of Oulu provides new insight into why some people develop allergic eye symptoms easily, while others ...
Zdeněk Hel plans legal action after Peter Kotlár questioned vaccine safety and the origins of Covid-19 at a seminar in Prague ...
EPS growth.Continued profitable growth expected in 2026 Paris, January 29, 2026 Q4 sales growth of 13.3% at CER1 and business earnings per share (EPS)2 of €1.53 Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results